ARCHIVES

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

This article is from The Cancer Letter archive.

Vol. 08 No. 17 | April 23, 1982

Download PDF Visit The Full Archive

Related Articles

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001